Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10351553 Potassium channel modulators

Patent 10351553 was granted and assigned to Cadent Therapeutics on July, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Cadent Therapeutics

Current Assignee

Cadent Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103515530

Patent Inventor Names

Thomas Amos Jacobsen0

Karin Sandager Nielsen0

Kelly Foster0

Martin R. Jefson0

Dipak Vasantrao Amrutkar0

Gregg F. Keaney0

Janus Schreiber Larsen0

Date of Patent

July 16, 2019

Patent Application Number

159382920

Date Filed

March 28, 2018

Patent Citations Received

‌

US Patent 11993586 Crystalline forms of potassium channel modulators

‌

US Patent 10717728 Potassium channel modulators

‌

US Patent 10774064 Potassium channel modulators

Patent Primary Examiner

‌

Jeffrey H Murray

Patent abstract

Provided herein are compounds of the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10351553 Potassium channel modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API